Nonsmokers Can Still Benefit from Medical Cannabis
Medical Marijuana Reclassified Under International Law?
Medical marijuana could receive a much-needed reclassification under international law before 2018.
The World Health Organization’s Expert Committee on Drug Dependence (ECDD), which has played in integral role throughout the years in how marijuana is revered in the eyes of the United Nations, has decided to give some consideration to whether “medical marijuana” should be downgraded from its current classification under the UN Single Convention.
The organization revealed plans last month to hold a special session within the next year and a half to debate this issue, according to a report from Americans for Safe Access (ASA).
A ‘light at the end of the tunnel’ for long-awaited medical marijuana program
Connecticut Hospice Hopes to Set New Standard for End of Life Patients with Medical Marijuana
The nation’s first hospice center plans to study how medical marijuana can help its dying patients.
Officials at the the Connecticut Hospice in Branford, established in 1974, said on Monday that they are hoping to improve pain management while reducing opioid use in palliative care.
They also want to decrease nausea and vomiting, while improving patients’ appetites and overall well-being.
The focus of this groundbreaking medical marijuana study will be to ease end of life patients’ pain and improve their quality of life, said Dr. Wen-Jen Hwu, professor of medical oncology at the MD Anderson Cancer Center, in a news conference announcing the research.
After State Legalizes Recreational Pot, Governor Wants to End Medical Marijuana
Governor Paul LePage failed to convince Maine voters that legalizing recreational marijuana would be a “deadly” disaster for the state. So now, the avowed Donald Trump supporter is trying to do away with medical marijuana.
Maine voters on Election Day appeared to narrowly approve Question 1, which legalizes two and a half ounces of cannabis and six mature plants for adults 21 and over. But with the margin of victory less than one percent of the vote, legalization opponents called for a recount.
Results from the recount, already delayed thanks to a lack of volunteers from the opposing side to help count, will now have to wait until 2017, as state election officials paused the process Friday for a two-week winter holiday break.
Company Behind CBD-Based Drug Leads Way Despite Trump, Economic Fears
Having expressed understandable apprehension due to recent political events in the U.S. and Britain (i.e. Trump’s election and Brexit), London-based GW Pharmaceuticals announced on Monday that they suffered a 62 percent revenue drop for 2016.
However, things turned around quickly.
GW’s stock jumped 5.5 percent on the first day of the new trading week, right after the company announced positive results for one of its flagship therapies, Epidiolex. This cannabidiol-based drug treats two of the most difficult-to-treat forms of epilepsy, especially in children: Dravet Syndrome and Lennox-Gastaut Syndrome.
“We are making very good progress toward a NDA [UK’s equivalent of the FDA] submission to the FDA, as well as preparations for commercial launch and look forward to the opportunity to make this important new medicine available to patients as quickly as possible,” said Justin Glover, GW’s Chief Executive Officer, on the company’s website.
- 193,056 Views Category: Odd
- 152,055 Views Category: Fun
- 141,546 Views Category: Culture
- 103,770 Views Category: Culture
- 102,260 Views Category: Culture
- 101,307 Views Category: Fun
- 81,833 Views Category: Culture
- 79,992 Views Category: Odd
- 71,934 Views Category: Fun
- 65,317 Views Category: Fun